Search research articles
Contact Us
Filters
Showing results (11-20 of 104) with videos related to
Page
of 11
Sort By:
Expert Review of Anti-Infective Therapy
|
July 31, 2014
Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection
Ivan Gentile, Antonio Riccardo Buonomo, Guglielmo Borgia
Infectious Diseases (London, England)
|
March 21, 2017
Hepatitis B mother-to-child transmission and infants immunization: we have not come to the end of the story yet
Guglielmo Borgia, Alberto Enrico Maraolo, Ivan Gentile
Expert Opinion on Investigational Drugs
|
April 5, 2019
An update on recent developments in the search for hepatitis C virus therapies with pan-genotypic efficacy
Guglielmo Borgia, Riccardo Scotto, Antonio Riccardo Buonomo
Expert Review of Anti-Infective Therapy
|
September 7, 2016
What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?
Ivan Gentile, Alberto Enrico Maraolo, Guglielmo Borgia
Reviews on Recent Clinical Trials
|
June 3, 2014
Dasabuvir: A Non-Nucleoside Inhibitor of NS5B for the Treatment of Hepatitis C Virus Infection
Ivan Gentile, Antonio R Buonomo, Guglielmo Borgia
Gastroenterology
|
September 7, 2005
CpG and Toll-like receptor 9 in primary biliary cirrhosis: a possible intracellular interaction from virus exposure?
Alessandro Perrella, Guglielmo Borgia, Marco Perrella, et al.
Therapeutics and Clinical Risk Management
|
May 14, 2009
Tenofovir and its potential in the treatment of hepatitis B virus
Laura Reynaud, Maria Aurora Carleo, Maria Talamo, et al.
Le Infezioni in Medicina
|
March 22, 2014
Is it possible to predict HCV-related liver cirrhosis non-invasively through routine laboratory parameters?
Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, et al.
Expert Review of Anti-Infective Therapy
|
June 12, 2014
Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?
Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, et al.
Expert Opinion on Investigational Drugs
|
November 12, 2014
Discontinued drugs in 2012 - 2013: hepatitis C virus infection
Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 104) with videos related to
Sort By:
Page
of 11
Expert Review of Anti-Infective Therapy
|
July 31, 2014
Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection
Ivan Gentile, Antonio Riccardo Buonomo, Guglielmo Borgia
Infectious Diseases (London, England)
|
March 21, 2017
Hepatitis B mother-to-child transmission and infants immunization: we have not come to the end of the story yet
Guglielmo Borgia, Alberto Enrico Maraolo, Ivan Gentile
Expert Opinion on Investigational Drugs
|
April 5, 2019
An update on recent developments in the search for hepatitis C virus therapies with pan-genotypic efficacy
Guglielmo Borgia, Riccardo Scotto, Antonio Riccardo Buonomo
Expert Review of Anti-Infective Therapy
|
September 7, 2016
What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?
Ivan Gentile, Alberto Enrico Maraolo, Guglielmo Borgia
Reviews on Recent Clinical Trials
|
June 3, 2014
Dasabuvir: A Non-Nucleoside Inhibitor of NS5B for the Treatment of Hepatitis C Virus Infection
Ivan Gentile, Antonio R Buonomo, Guglielmo Borgia
Gastroenterology
|
September 7, 2005
CpG and Toll-like receptor 9 in primary biliary cirrhosis: a possible intracellular interaction from virus exposure?
Alessandro Perrella, Guglielmo Borgia, Marco Perrella, et al.
Therapeutics and Clinical Risk Management
|
May 14, 2009
Tenofovir and its potential in the treatment of hepatitis B virus
Laura Reynaud, Maria Aurora Carleo, Maria Talamo, et al.
Le Infezioni in Medicina
|
March 22, 2014
Is it possible to predict HCV-related liver cirrhosis non-invasively through routine laboratory parameters?
Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, et al.
Expert Review of Anti-Infective Therapy
|
June 12, 2014
Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?
Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, et al.
Expert Opinion on Investigational Drugs
|
November 12, 2014
Discontinued drugs in 2012 - 2013: hepatitis C virus infection
Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, et al.
Page
of 11